See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot3,994▼ 0.75%WTI103.27▲ 3.82%
← XRO page
XStocksXray
Market X-Ray report · 23 October 2026

Xero Ltd (XRO)

Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026

Key indicators

Last closeAUD 64.19
52-week range55.09 – 154.26
Return, 1 month / 3 months+10.3% / −0.4%
Return, 1 year / 3 years−57.3% / −40.5%
TrendBelow its 200-day average
RSI (14)55
Volatility (1 year)50.6%
Worst drawdown (1 year)-64.0%
Average daily value traded65.36M AUD
Dividend yield–

Market X-Ray price-based

53/ 100 · High confidence · ahead of 54% of stocks on this exchange
Trend41
Momentum39
Stability (higher is calmer)51
Liquidity98
Income–

Five-year price chart navy: price · brown: 200-day average

46.9885.871251642032021-112023-022024-052025-072026-10

About the company

Xero is a software company that provides cloud-based accounting and business management tools, mainly for small and medium-sized businesses and their accountants. Its platform handles bookkeeping, invoicing, bank reconciliation, payroll and expense tracking, and it connects to banks and other business applications. The company is based in New Zealand and serves customers in many countries through its online subscription service.

The shares are listed on the Australian Securities Exchange in Australia under the code XRO, and the price on this page is in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Xero Ltd (XRO) trades on the Australian Securities Exchange in Australia. It last closed at AUD 64.19 on 23 October 2026.

Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 840 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 57.3% and over the last three months it fell 0.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Xero Ltd (XRO)

The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange

Lens and metricValueScoreReading
Trend41 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-15.8%
From 52-week high-58.3%
Momentum39 · WeakLagging most stocks on this exchange.
3-month return-0.4%
6-month return-21.0%
12-month return, skipping the last month-61.3%
Stability (higher is calmer)51 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)50.6%
Worst drawdown, 1 year (smaller is calmer)-64.0%
Liquidity98 · StrongTrades actively.
Average daily value traded65.36M AUD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.

Returns

1 week+3.9%
1 month+10.3%
3 months−0.4%
6 months−21.0%
1 year−57.3%
3 years−40.5%
5 years−57.1%

Signals

50-day / 200-day average68.44 / 76.24
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.83

Technical summary

DailyBearish5 bullish · 1 neutral · 10 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 25 Oct 2026